Skip to main content
Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
11.87
+0.55 (4.86%)
At close: Mar 9, 2026, 4:00 PM EDT
12.10
+0.23 (1.94%)
After-hours: Mar 9, 2026, 6:57 PM EDT

Xencor Revenue

In the year 2025, Xencor had annual revenue of $125.58M with 13.65% growth. Xencor had revenue of $28.24M in the quarter ending December 31, 2025, a decrease of -46.51%.

Revenue (ttm)
$125.58M
Revenue Growth
+13.65%
P/S Ratio
6.93
Revenue / Employee
$482,985
Employees
260
Market Cap
870.53M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025125.58M15.08M13.65%
Dec 31, 2024110.49M-64.12M-36.72%
Dec 31, 2023174.62M10.04M6.10%
Dec 31, 2022164.58M-110.53M-40.18%
Dec 31, 2021275.11M152.42M124.23%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MannKind 348.97M
Arvinas 262.60M
Phathom Pharmaceuticals 175.11M
CytomX Therapeutics 113.63M
Evommune 13.00M
Janux Therapeutics 10.00M
KalVista Pharmaceuticals 1.43M
Revenue Rankings

XNCR News

More News